A Serendipitous Mutation Reveals the Severe Virulence Defect of a Mutant
Overview
Parasitology
Affiliations
is considered a significant public health threat because of the emergence of multidrug-resistant strains and the challenge associated with treating life-threatening infections. Capsule, siderophores, and adhesins have been implicated as virulence determinants of , yet we lack a clear understanding of how this pathogen causes disease. In a previous screen for virulence genes, we identified a potential new virulence locus and constructed a mutant () with this locus deleted. In this study, we characterize the mutant and show that this mutation renders avirulent in a pneumonia model of infection. The mutant was expected to have a deletion of three genes, but subsequent genome sequencing indicated that a much larger deletion had occurred. Further analysis of the deleted region indicated that the virulence defect of the mutant could be attributed to the loss of FepB, a periplasmic protein required for import of the siderophore enterobactin. Interestingly, a Δ mutant was more attenuated than a mutant unable to synthesize enterobactin, suggesting that additional processes are affected. As FepB is highly conserved among the members of the family , therapeutic targeting of FepB may be useful for the treatment of and other bacterial infections. In addition to having a reputation as the causative agent of several types of hospital-acquired infections, has gained widespread attention as a pathogen with a propensity for acquiring antibiotic resistance. It is capable of causing a range of infections, including urinary tract infections, pneumonia, and sepsis. Because of the rapid emergence of carbapenem resistance among strains, there is a dire need for a better understanding of virulence mechanisms and identification of new drug targets. Here, we identify the periplasmic transporter FepB as one such potential target.
Bray A, Broberg C, Hudson A, Wu W, Nagpal R, Islam M Nat Commun. 2025; 16(1):940.
PMID: 39843522 PMC: 11754592. DOI: 10.1038/s41467-025-56309-8.
Chandrashekarappa D, Van Allen M, Bina X, Bina J Plasmid. 2024; 131-132:102734.
PMID: 39481464 PMC: 11788892. DOI: 10.1016/j.plasmid.2024.102734.
Park G, Kadyan S, Hochuli N, Salazar G, Laitano O, Chakrabarty P J Infect Dis. 2024; 230(Supplement_2):S95-S108.
PMID: 39255397 PMC: 11385593. DOI: 10.1093/infdis/jiae165.
Jauvain M, Carrer M, Palma F, Chapuzet C, Courat N, Heslan C Eur J Clin Microbiol Infect Dis. 2024; 43(8):1655-1659.
PMID: 38869685 DOI: 10.1007/s10096-024-04870-3.
Cherrak Y, Salazar M, Yilmaz K, Kreuzer M, Hardt W PLoS Biol. 2024; 22(6):e3002616.
PMID: 38865418 PMC: 11168627. DOI: 10.1371/journal.pbio.3002616.